In parallel, recent studies have also shown that a small group of lung cancer patients with low PD-1 expression and high miR-33a levels had a better treatment outcome, indicating the better prognostic value of miR-33a via PD-1 regulation. The gene discussed is PDCD1; the disease is lung cancer.